Hello, We Are
Lifelong Health Intelligence
An AI-driven genomics company that provides secure, precise, and reliable biological data enabling anyone to take control of their health, throughout their lives.

Our Services

We offer physicians and their patients comprehensive data-driven genomic insight into the state of health at all stages of life. Our wide range of health data services provides physicians and patients with accessible, precise molecular-level information to support tailored proactive health management and healthcare decisions to maximize healthspan.

Wellness & Prevention

  • Nutrition risk management via DNA and microbiome
  • Insights on genetics and habits impacting health
  • Long-term prevention with professional nutritionists consultation
Visit Website

Prognosis, Diagnostics & Treatment

  • Specialized genetic tests for personalized oncology, prenatal, rare diseases, and microbiome
  • Supplemented by telemedicine consultations with medical geneticists
Visit Website

Our Team

World-class leadership team with the global experience, expertise and track record required to integrate the companies and execute ambitious growth plans.

Fabian
Fay, MSc

Heritas co-founder. Biochemist, molecular biologist and veteran laboratory owner and diagnostics operator. President of ALADIL (Latam Association of Diagnostic Labs).

Marius
Calmet, MBA

Business development leader with 15+ years across Latin America, former CEO of Heritas, specializing in M&A and strategic reorganizations.

Ramiro
Huidobro, MBA

With over 15 years of experience in strategy and transformation, Ramiro has a proven track record of delivering strong financial and operational results

Martin
Vazquez, Ph.D

Biotech innovator and Heritas co-founder, with a decade in genomic research and extensive background in academic and strategic roles.

Investor Relations

Press Releases

March 26 2024

APx Acquisition Corp. I, OmnigenicsAI Corp and MultiplAI Health Ltd enter into Business Combination Agreement to create a global AI-driven genomics platform

View Press Release

Contact Us